ea0077ec1.3 | Clinical Endocrinology Trust Best Abstract Clinical | SFEBES2021
Merke Deborah P
, Mallappa Ashwini
, Arlt Wiebke
, De La Perriere Aude Brac
, Hirschberg Angelica Linden
, Juul Anders
, Newell-Price John D C
, Perry Colin Graham
, Prete Alessandro
, Rees Aled
, Reisch Nicole
, Stikkelbroeck Monica
, Touraine Philippe A
, Lewis Alexander
, Maltby Kerry
, Treasure Peter
, Porter John
, Ross Richard John M
Background: Patients with congenital adrenal hyperplasia (CAH) due to classic 21-hydroxylase deficiency have poor health outcomes. We compared disease control in CAH adults treated with modified release hydrocortisone (MRHC, Chronocort®, Diurnal Ltd) versus standard glucocorticoid (GC).Methods: 6-month, Phase 3 study in 122 patients randomised to either MRHC twice daily or standard GC followed by safety extension study on MRHC. Patients had 24-hr 17...